Literature DB >> 20480156

A study of the first-generation pipeline embolization device morphology using intraoperative angiographic computed tomography (ACT).

Thaweesak Aurboonyawat1, Paul J Schmidt, Michel Piotin, Raphael Blanc, Laurant Spelle, Jacques Moret.   

Abstract

INTRODUCTION: The pipeline embolization device (PED, Chestnut Medical, Menlo Park, CA, USA) has been used in our department since September 2008. The first-generation PED had limited radio-opacity. Before September 2008, we began obtaining an angiographic computed tomography (ACT) before and after each procedure to detect intracranial complications. We retrospectively examined the ACT of our patient's with the PED to evaluate the in vivo stent morphology.
METHODS: Twelve patients had a PED placed in our department from September 2008 to January 2009. The stent morphology (stent profile and wall apposition) of three segments of each stent was evaluated.
RESULTS: Metal coils adjacent to the stent created too much artifact to evaluate the stent morphology in 4 of 12 patients. Two of the 12 patients were excluded for other reasons. Post-processing of the ACT images was necessary to optimize the evaluation of the stent morphology. Six intracranial PEDs could be adequately evaluated by the ACT, and for these particular cases, 18 of 18 stent segments showed an optimal stent profile and 14 of 18 stent segments showed optimal arterial wall apposition.
CONCLUSION: ACT provided detailed images of the morphology of the PED in six patients. ACT helped detect two stent segments that required balloon dilation to improve the stent-arterial wall apposition; and during the retrospective analysis (after refining post-processing techniques), we identified one additional stent with suboptimal arterial wall apposition. The main limitation of the ACT was the additional radiation dose to the patient.

Entities:  

Mesh:

Year:  2010        PMID: 20480156     DOI: 10.1007/s00234-010-0709-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  Angiographic CT in cerebrovascular stenting.

Authors:  Götz Benndorf; Charles M Strother; Benjamin Claus; Ramin Naeini; Hesham Morsi; Richard Klucznik; Michael E Mawad
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

2.  Stent conformity in curved vascular models with simulated aneurysm necks using flat-panel CT: an in vitro study.

Authors:  N Ebrahimi; B Claus; C-Y Lee; A Biondi; G Benndorf
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

3.  A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms.

Authors:  D F Kallmes; Y H Ding; D Dai; R Kadirvel; D A Lewis; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-15       Impact factor: 3.825

4.  Flat panel detector angiographic CT in the management of aneurysmal rupture during coil embolization.

Authors:  T Engelhorn; T Struffert; G Richter; M Doelken; O Ganslandt; W Kalender; A Doerfler
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

5.  Increased cell opening and prolapse of struts of a neuroform stent in curved vasculature: value of angiographic computed tomography: technical case report.

Authors:  Goetz Benndorf; Benjamin Claus; Charles M Strother; Lee Chang; Richard P Klucznik
Journal:  Neurosurgery       Date:  2006-04       Impact factor: 4.654

6.  Evaluation of angiographic computed tomography in the follow-up after endovascular treatment of cerebral aneurysms--a comparative study with DSA and TOF-MRA.

Authors:  Jan-Hendrik Buhk; Kai Kallenberg; Alexander Mohr; Peter Dechent; Michael Knauth
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

7.  Flat panel detector angiographic CT for stent-assisted coil embolization of broad-based cerebral aneurysms.

Authors:  G Richter; T Engelhorn; T Struffert; M Doelken; O Ganslandt; J Hornegger; W A Kalender; A Doerfler
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

8.  Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience.

Authors:  Pedro Lylyk; Carlos Miranda; Rosana Ceratto; Angel Ferrario; Esteban Scrivano; Hugh Ramirez Luna; Aaron L Berez; Quang Tran; Peter K Nelson; David Fiorella
Journal:  Neurosurgery       Date:  2009-04       Impact factor: 4.654

9.  A new endoluminal, flow-disrupting device for treatment of saccular aneurysms.

Authors:  David F Kallmes; Yong Hong Ding; Daying Dai; Ramanathan Kadirvel; Debra A Lewis; Harry J Cloft
Journal:  Stroke       Date:  2007-07-05       Impact factor: 7.914

10.  Angiographic CT with intravenous administration of contrast medium is a noninvasive option for follow-up after intracranial stenting.

Authors:  Jan-Hendrik Buhk; Paul Lingor; Michael Knauth
Journal:  Neuroradiology       Date:  2008-02-02       Impact factor: 2.804

View more
  4 in total

1.  Wall Apposition Is a Key Factor for Aneurysm Occlusion after Flow Diversion: A Histologic Evaluation in 41 Rabbits.

Authors:  A Rouchaud; C Ramana; W Brinjikji; Y-H Ding; D Dai; T Gunderson; J Cebral; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-07       Impact factor: 3.825

2.  Correlation of aneurysm occlusion with actual metal coverage at neck after implantation of flow-diverting stent in rabbit models.

Authors:  Kuizhong Wang; Qinghai Huang; Bo Hong; Zhen Li; Xinggen Fang; Jianmin Liu
Journal:  Neuroradiology       Date:  2011-08-27       Impact factor: 2.804

3.  Effects of metal coverage rate of flow diversion device on neointimal growth at side branch ostium and stented artery: an animal experiment in rabbit abdominal aorta.

Authors:  Bo Hong; Kuizhong Wang; Qinghai Huang; Yi Xu; Xinggen Fang; Zhen Li; Jianmin Liu
Journal:  Neuroradiology       Date:  2011-12-15       Impact factor: 2.804

4.  Efficacy and safety of flow diversion for paraclinoid aneurysms: a matched-pair analysis compared with standard endovascular approaches.

Authors:  G Lanzino; E Crobeddu; H J Cloft; R Hanel; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.